Head-to-head · Cost-Efficiency Index
Neuvé Health vs MyDrHank
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Neuvé Health
Readers who want the route and the base chosen explicitly and will ask what the monthly figure covers before enrolling.
Visit Neuvé HealthMyDrHank
Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.
Visit MyDrHankThe verdict
Neuvé Health takes it, leading the Cost-Efficiency Index 68 to 65. Neuvé Health prices twelve GLP-1 products openly — injectable and sublingual, standard and low dose, with a B12 or a glycine base — and then says three different things about whether the medication is inside the monthly figure. MyDrHank still earns a C — Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Neuvé Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Neuvé Health | MyDrHank |
|---|---|---|
| Cost-Efficiency Index | 68/100 | 65/100 |
| Semaglutide / mo | $217/month (standard injectable with B12; the site gives three different answers on whether the medication is inside the figure) | $249/mo oral, $259/mo injectable (yearly prepay: $171 / $178) |
| Tirzepatide / mo | $324/month (standard injectable with B12; same unresolved question about what the figure covers) | $349/mo month-to-month ($240/mo only on a year prepaid) |
| Semaglutide / yr (modeled) | $2,604 | $2,988 |
| Tirzepatide / yr (modeled) | $3,888 | $4,188 |
| Coverage | All 50 states | Not published; program excludes KS, LA, MS, NM, ND, WV |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #127 | #130 |
Neuvé Health
68/100Where the value is
- Prices twelve distinct GLP-1 products before any account: injectable and sublingual, standard and low dose, with a B12 or a B12-free glycine base for each
- States the 503A and 503B compounding classes on the homepage and the About page, which the August record did not find
- Names its founder as a nurse practitioner with a care role rather than referring only to an anonymous network
The tradeoffs
- Three surfaces disagree on whether the medication is inside the monthly price: the weight-loss page is headed "All-in monthly pricing" and lists the compounded drug as included, while its own fine print and the financial policy say medication, labs and supplies are billed separately
- The clinical partner that would settle that question — and that bills for the medication, the labs and the consultation — is never named
MyDrHank
65/100Where the value is
- The price does not change as your dose is titrated up — its FAQ states it plainly ("The price stays the same at every dose — no surprise price increases"), and dose-indexed pricing is the single most common way a cheap first month becomes an expensive fourth one
- A genuine oral route on semaglutide: a daily tablet, including one compounded with low-dose ondansetron specifically to blunt the nausea that ends most GLP-1 courses early
- The entire price ladder is public — monthly, quarterly, 6-month and yearly, with the total for each term printed beside the per-month figure — before any quiz, intake or email capture
The tradeoffs
- EVERY price the site advertises is a twelve-month prepay rate, and not by accident: the price display is coded to return the cheapest term in the ladder, so "From $X/mo" is always the yearly figure. No page shows a month-to-month rate beside it
- What the twelve months actually cost, up front: oral semaglutide $2,057 to reach the advertised $171/mo, injectable semaglutide $2,140 to reach $178/mo, and tirzepatide $2,883 to reach $240/mo
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.